Publications
-
02 March 2012 /Statistics, prices and reimbursement
Number of applications for individual reimbursement of medicines in 2011
In 2011, the Danish Medicines Agency (now the Danish National Board of Health) reviewed approx. 103,000 applications for single reimbursement (about 7 % more than in 2010), approx. 26,000 applications for reimbursement for the chronically ill (about 30 % less than in 2010), approx. 12,000 applications for reimbursement for the terminally ill (about 3 % more than in 2010) and approx. 2,500 applications for increased reimbursement (about 12 % less than in 2010), cf. table 1.
-
31 January 2012 /Side effects and trials
Long-term treatment of osteoporosis patients with bisphosphonates
At present, there is very limited knowledge about long-term treatment with bisphosphonates for osteoporosis patients. But over the past years, reports suggestive of long-term adverse reactions have been submitted, e.g. osteonecrosis of the jaw and atypical fractures.
-
25 January 2012 /Statistics, prices and reimbursement
-
16 January 2012 /Statistics, prices and reimbursement
-
03 January 2012 | Updated 04 January 2012 /Statistics, prices and reimbursement
-
21 November 2011 | Updated 30 November 2011 /Statistics, prices and reimbursement
-
20 January 2005 | Updated 21 November 2011 /About us
-
17 February 2005 | Updated 04 November 2011 /Statistics, prices and reimbursement
-
28 October 2011 /Product areas
-
25 October 2011 /Statistics, prices and reimbursement
-
12 October 2011 /Side effects and trials
-
12 September 2011 /Authorisation and supervision
-
24 August 2011 /Retail and online sale
-
12 August 2011 /Product areas
-
12 August 2011 /Statistics, prices and reimbursement
-
05 August 2011 /Statistics, prices and reimbursement
-
22 July 2011 /Authorisation and supervision
-
15 April 2011 | Updated 05 July 2011 /Statistics, prices and reimbursement
-
20 June 2011 /Side effects and trials
-
14 June 2011 /Statistics, prices and reimbursement

